(S)-tetrahydro-2H-pyran-3-carbaldehyde

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧烷类
• 英文名称: (S)-tetrahydro-2H-pyran-3-carbaldehyde
• 英文别名: (3S)-oxane-3-carbaldehyde
• 化学式: C₆H₁₀O₂
• 分子量: 114.14
• InChiKey: KYHPVAHPKYNKOR-ZCFIWIBFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Pyrazolo[1,5-a]pyridines and medicines containing the same
  申请人：——

  公开号：US20040122039A1

  公开（公告）日：2004-06-24

  Compounds represented by the general formula: 1 [wherein R 1 represents methoxy, ethyl, methylthio, etc., R 2 , R 3 and R 4 each represent hydrogen, a halogen, etc., R 5 and R 6 each represent —X 5 —X 6 —X 7 (wherein X 5 represents a single bond or —CO—, X 6 represents a single bond, —NR 3a , etc. and X 7 and R 3a each represent hydrogen, C 1-10 alkyl, etc.), and Ar represents phenyl, pyridyl, etc.], salts thereof and hydrates of the foregoing.

  化合物的一般式表示为1，其中R1表示甲氧基，乙基，甲硫基等，R2，R3和R4分别表示氢，卤素等，R5和R6分别表示—X5—X6—X7（其中X5表示单键或—CO—，X6表示单键，—NR3a等，X7和R3a各自表示氢，C1-10烷基等），Ar表示苯基，吡啶基等，其盐和上述化合物的水合物。
• Pyrazolo[1,5-a] pyridines and medicines containing the same
  申请人：Hibi Shigeki

  公开号：US20060217348A1

  公开（公告）日：2006-09-28

  Compounds represented by the general formula: [wherein R 1 represents methoxy, ethyl, methylthio, etc., R 2 , R 3 and R 4 each represent hydrogen, a halogen, etc., R 5 and R 6 each represent —X 5 —X 6 —X 7 (wherein X 5 represents a single bond or —CO—, X 6 represents a single bond, —NR 3a , etc. and X 7 and R 3a each represent hydrogen, C 1-10 alkyl, etc.), and Ar represents phenyl, pyridyl, etc.], salts thereof and hydrates of the foregoing.

  化合物的一般公式表示为：[其中R1代表甲氧基、乙基、甲硫基等，R2、R3和R4各代表氢、卤素等，R5和R6各代表—X5—X6—X7（其中X5代表单键或—CO—，X6代表单键、—NR3a等，X7和R3a各代表氢、C1-10烷基等），Ar代表苯基、吡啶基等]，其盐和上述化合物的水合物。
• PYRAZOLO[1,5-a]PYRIDINES AND MEDICINES CONTAINING THE SAME
  申请人：Hibi Shigeki

  公开号：US20070249663A1

  公开（公告）日：2007-10-25

  Compounds represented by the general formula: [wherein R 1 represents methoxy, ethyl, methylthio, etc., R 2 , R 3 and R 4 each represent hydrogen, a halogen, etc., R 5 and R 6 each represent —X 5 —X 6 —X 7 (wherein X 5 represents a single bond or —CO—, X 6 represents a single bond, —NR 3a , etc. and X 7 and R 3a each represent hydrogen, C 1-10 alkyl, etc.), and Ar represents phenyl, pyridyl, etc.], salts thereof and hydrates of the foregoing.

  由一般式表示的化合物：[其中R1代表甲氧基，乙基，甲硫基等，R2，R3和R4各代表氢，卤素等，R5和R6各代表—X5—X6—X7（其中X5代表单键或—CO—，X6代表单键，—NR3a等，X7和R3a各代表氢，C1-10烷基等），而Ar代表苯基，吡啶基等]，其盐和上述化合物的水合物。
• PROCESSES FOR PREPARING DIHYDROPYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF
  申请人：SUNSHINE LAKE PHARMA CO., LTD.

  公开号：US20160244438A1

  公开（公告）日：2016-08-25

  The present invention relates to processes for preparing a dihydropyrimidine derivative having Formula (I) or a tautomer thereof having Formula (Ia), as well as a intermediate thereof. The processes of the invention have simple operation, high optical purity of product, high yield and convenient work-up, which is suitable for industrial production.

  本发明涉及制备具有式(I)的二氢嘧啶衍生物或具有式(Ia)的其互变异构体以及其中间体的方法。本发明的方法操作简单，产物的光学纯度高，收率高且操作方便，适合于工业生产。
• PYRAZOLO 1,5-A]PYRIDINES AND MEDICINES CONTAINING THE SAME
  申请人：Eisai Co., Ltd.

  公开号：EP1389618A1

  公开（公告）日：2004-02-18

  Compounds represented by the general formula: [wherein R1 represents methoxy, ethyl, methylthio, etc., R2, R3 and R4 each represent hydrogen, a halogen, etc., R5 and R6 each represent -X5-X6-X7 (wherein X5 represents a single bond or -CO-, X6 represents a single bond, -NR3a, etc. and X7 and R3a each represent hydrogen, C1-10 alkyl, etc.), and Ar represents phenyl, pyridyl, etc.], salts thereof and hydrates of the foregoing.

  通式所代表的化合物： [其中R1代表甲氧基、乙基、甲硫基等，R2、R3和R4各自代表氢、卤素等，R5和R6各自代表-X5-X6-X7（其中X5代表单键或-CO-，X6代表单键、-NR3a等，X7和R3a各自代表氢、C1-10烷基等），Ar代表苯基、吡啶基等]的化合物、其盐和上述化合物的水合物。